Lexeo Therapeutics
Biotechnology Research • 
Manhattan, New York, United States • 51-100 Employees
Company overview
| Headquarters | 345 Park Avenue South, 6th Floor, New York, New York 10010, US |
| Phone number | +12125479879 |
| Website | |
| NAICS | 541714 |
| Founded | 2018 |
| Employees | 51-100 |
| Socials |
Key Contacts at Lexeo Therapeutics
Nirav Desai
Director, Assistant Controller
Frank Borchetta
Senior Director, Head Ip Counsel
Bhavna Verma
Associate Director, Clinical Bioanalytical/Biomarkers
Anthony Morano
Director Of Information Technology And Cybersecurity
Nilomi Shah
Senior Director, Medical Affairs Lead
Nithya Selvan
Director, Bioanalytical Development And Quality
Peter Graham
Associate Director, Program And Portfolio Management At Lexeo Therapeutics
Tara Hun-Dorris
Senior Director, Medical Writing
Reinaldo M. Diaz
Member Board Of Directors
Natalie Sukramani
Director, Executive Operations
Lexeo Therapeutics Email Formats
Lexeo Therapeutics uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@lexeotx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@lexeotx.com | 100% |
About Lexeo Therapeutics
Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4 associated Alzheimer's disease programs, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.
Lexeo Therapeutics revenue & valuation
| Annual revenue | $654,000 |
| Revenue per employee | $9,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,100,000 |
| Total funding | $215,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Lexeo Therapeutics has 43 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore Lexeo Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Lexeo Therapeutics Tech Stack
Discover the technologies and tools that power Lexeo Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Blogs
Hosting
Analytics
SEO
Spain
United Arab Emirates
Serbia
Frequently asked questions
4.8
40,000 users
